IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Physical medicine and rehabilitation in New Jersey

In 2025 Q1–Q4, the provider or facility offer prevailed in 84.4% of 697 determined Federal IDR dispute line items for physical medicine and rehabilitation in New Jersey. The median prevailing offer was 75.48x the QPA (25th–75th percentile 13.29x–154.26x; n = 654). The median time to a decision was 33 business days (n = 697).

Determined line items

697

2025 Q1–Q4 · 0 split decisions excluded

Provider win rate

84.4%

n = 697 · 2025 Q1–Q4

Median payment vs QPA

75.48x †

middle half 13.29x–154.26x · n = 654 · 2025 Q1–Q4

Median days to decision

33

business days, from dispute initiation · n = 697 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q469784.4%75.48x †13.29x–154.26x65433
2024 Q1–Q45676.8%11.96x6.39x–40.93x5231
2023 Q1–Q4Fewer than 30 determined line items; not shown.
2023 Q1–2025 Q475483.8%67.58x †9.40x–149.25x707not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
64493 Injection of lower or sacral spine facet joint using imaging guidance, single le7582.7%143.37x †7428
64494 Injection of lower or sacral spine facet joint using imaging guidance, second le6587.7%216.05x †6429
99232 Subsequent hospital care with moderate levelof medical decision making, if using5881.0%13.29x5870
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using i5587.3%80.10x †5028
64636 Destruction of lower or sacral spinal facet joint nerves using imaging guidance,4680.4%149.25x †4628.5
64491 Injection of upper or middle spine facet joint using imaging guidance, second le3994.9%142.28x †3931
64490 Injection of upper or middle spine facet joint using imaging guidance, single le3775.7%100.79x †3528
64495 Injection of lower or sacral spine facet joint using imaging guidance, third and3488.2%176.64x †3425

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in New Jersey · Physical medicine and rehabilitation in all states

FAQ

What is the Federal IDR provider win rate for physical medicine and rehabilitation in New Jersey?

In 2025 Q1–Q4, the provider or facility offer was selected in 84.4% of 697 determined dispute line items for physical medicine and rehabilitation in New Jersey. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for physical medicine and rehabilitation in New Jersey?

In 2025 Q1–Q4, the median prevailing offer was 75.48x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 13.29x to 154.26x (n = 654 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for physical medicine and rehabilitation in New Jersey?

In 2025 Q1–Q4, the median was 33 business days (n = 697 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR